SOURCE-LINKED STUDY SUMMARY
Postoperative outcomes after total knee arthroplasty in type 2 diabetes mellitus patients receiving semaglutide versus tirzepatide: a propensity score-matched national research network analysis.
Abstract summarizedQuality not appraised
- What was studied
- A retrospective comparison of short-term outcomes after knee replacement among people prescribed semaglutide versus tirzepatide.
- Who / model studied
- Adults with type 2 diabetes undergoing knee replacement were matched into 415 pairs. Outcomes were tracked through 90 and 180 days.
- Studied dose & schedule
- Dose and schedule were not reported in the source used for this summary.
- What the study found
- The groups had no statistically clear differences in overall medical complications by 90 days, surgical complications by 180 days, individual listed events, emergency visits or readmissions.
- Limitations & context
- This prescription-based observational comparison cannot establish equal safety in all surgical patients. Several outcomes were uncommon, reducing precision.
Read summary source ↗ · Prepared 9/15/2026 · AI-assisted, source-based summary
Review record & corrections
Summary prepared: . Source scope: abstract. This is an AI-assisted source summary, not an independent clinician sign-off.
No public field-by-field revision history is available for this card yet. The date above is the summary date, not proof that every field was updated then.
Inspect the source · Correction policyResearch findings apply to the population and conditions studied. This educational summary is not a treatment recommendation or a formal assessment of study quality.
Original publication ↗ · DOI: 10.1016/j.knee.2026.104639